Ingevity Balance Sheet
NYSE: NGVTIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ingevity financial position
At the end of fiscal 2025, Ingevity reported total assets of $1.65 billion, down 18.4% from a year earlier against total liabilities of $1.62 billion. Shareholders' equity stood at $29.7 million, or 1.8% of assets. The company held $78.1 million in cash and equivalents against $1.21 billion of debt, a net debt position of $1.13 billion.
The current ratio (current assets divided by current liabilities) was 1.33, meaning short-term assets cover obligations due within a year. Debt-to-equity was 40.69.
Summary generated from market data by MetaCap's automated system. Methodology
Ingevity balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 78.10M | 68.00M | 95.90M | 76.70M | 275.40M | 257.70M | 56.50M | 77.50M | 87.90M | 30.50M |
| Receivables | — | — | — | — | — | 148.00M | 150.00M | 118.90M | 100.00M | 89.80M |
| Inventory | 186.00M | 195.90M | 308.80M | 335.00M | 241.20M | 189.00M | 212.50M | 191.40M | 160.00M | 151.20M |
| Total Current Assets | 454.20M | 493.20M | 658.60M | 683.30M | 724.90M | 628.70M | 463.20M | 422.70M | 368.70M | 295.20M |
| Property, Plant & Equipment | 608.10M | 642.90M | 762.20M | 798.60M | 719.70M | 703.60M | 664.70M | 523.80M | 438.50M | 422.80M |
| Goodwill | 4.30M | 175.20M | 527.50M | 518.50M | 442.00M | 445.30M | 436.40M | 130.70M | 12.40M | 12.40M |
| Intangible Assets | 176.10M | 278.80M | 336.10M | 404.80M | 337.60M | 373.30M | 396.20M | 125.60M | 4.90M | 7.30M |
| Long-Term Investments | — | — | — | — | 35.30M | 0 | — | — | — | — |
| Total Assets | 1.65B | 2.02B | 2.62B | 2.74B | 2.47B | 2.33B | 2.14B | 1.32B | 929.60M | 832.80M |
| Accounts Payable | 92.00M | 94.50M | 158.40M | 174.80M | 125.80M | 104.20M | 99.10M | 92.90M | 83.10M | 79.20M |
| Short-Term Debt | 47.10M | 61.30M | 84.40M | 900.00K | 19.60M | 26.00M | 22.50M | 11.20M | 9.40M | 7.50M |
| Total Current Liabilities | 341.30M | 264.10M | 362.90M | 303.50M | 268.90M | 223.40M | 215.50M | 183.30M | 153.20M | 136.90M |
| Long-Term Debt | 1.16B | 1.34B | 1.38B | 1.47B | 1.25B | 1.27B | 1.23B | 741.20M | 444.00M | 481.30M |
| Total Liabilities | 1.62B | 1.83B | 1.99B | 2.04B | 1.80B | 1.69B | 1.61B | 976.50M | 651.70M | 698.20M |
| Shareholders' Equity | 29.70M | 195.20M | 631.40M | 698.30M | 673.80M | 642.10M | 530.80M | 338.70M | 277.90M | 127.00M |
| Retained Earnings | 404.90M | 572.00M | 1.00B | 1.01B | 796.10M | 678.00M | 497.20M | 313.50M | 142.80M | 16.00M |
| Total Debt | 1.21B | 1.40B | 1.47B | 1.47B | 1.27B | 1.29B | 1.25B | 752.40M | 453.40M | 488.80M |
| Net Cash (Debt) | -1.13B | -1.33B | -1.37B | -1.40B | -994.20M | -1.04B | -1.19B | -674.90M | -365.50M | -458.30M |
| Shares Outstanding | 35.49M | 36.35M | 36.23M | 37.30M | 39.27M | 40.51M | 41.83M | 41.69M | 42.09M | 42.12M |
This table shows 10 annual periods of Ingevity's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow NGVT's reporting calendar. What is a balance sheet?